Toll Free: 1-888-928-9744

Post-Operative Pain Global Clinical Trials Review, H1, 2016

Published: Mar 16, 2016 | Pages: 1697 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Post-Operative Pain Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Post-Operative Pain Global Clinical Trials Review, H1, 2016" provides an overview of Post-Operative Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Post-Operative Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Post-Operative Pain to Central Nervous System Clinical Trials 15 Clinical Trials by Phase in G7 Countries 17 Clinical Trials in G7 Countries by Trial Status 18 Clinical Trials by E7 Countries: Proportion of Post-Operative Pain to Central Nervous System Clinical Trials 19 Clinical Trials by Phase in E7 Countries 21 Clinical Trials in E7 Countries by Trial Status 22 Clinical Trials by Phase 23 In Progress Trials by Phase 24 Clinical Trials by Trial Status 25 Clinical Trials by End Point Status 26 Subjects Recruited Over a Period of Time 27 Clinical Trials by Sponsor Type 28 Prominent Sponsors 29 Top Companies Participating in Post-Operative Pain Therapeutics Clinical Trials 30 Prominent Drugs 32 Latest Clinical Trials News on Post-Operative Pain 33 Mar 07, 2016: AcelRx Pharmaceuticals Initiates Phase 3 Study of ARX-04 in Patients with Post-Operative Moderate-to-Severe Acute Pain 33 Feb 25, 2016: AcelRx Pharmaceuticals Moderate-to-Severe Acute Pain Candidate ARX-04 Shows Improved Pain Scores in ER Patients in Interim Phase 3 Analysis 33 Feb 01, 2016: Recro Pharma Initiates Second Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain 34 Jan 27, 2016: Recro Pharma Initiates Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain 34 Jan 21, 2016: AcelRx Pharmaceuticals Announces Presentation of Phase 3 Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European Congress of Ambulatory Surgery 35 Jan 08, 2016: AcelRx Completes Protocol Review with FDA and Plans to Initiate Phase 3 Open-Label Study (IAP312) for Zalviso in 1Q 2016 35 Clinical Trial Profile Snapshots 37 Appendix 1694 Abbreviations 1694 Definitions 1694 Research Methodology 1695 Secondary Research 1695 About GlobalData 1696 Contact Us 1696 Disclaimer 1696 Source 1697
List of Tables
Post-Operative Pain Therapeutics, Global, Clinical Trials by Region, 2016* 6 Post-Operative Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Post-Operative Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Post-Operative Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Post-Operative Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Post-Operative Pain Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Post-Operative Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Post-Operative Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Post-Operative Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 16 Post-Operative Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17 Post-Operative Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18 Proportion of Post-Operative Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 20 Post-Operative Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21 Post-Operative Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22 Post-Operative Pain Therapeutics, Global, Clinical Trials by Phase, 2016* 23 Post-Operative Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 24 Post-Operative Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25 Post-Operative Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26 Post-Operative Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27 Post-Operative Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 28 Post-Operative Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29 Post-Operative Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31 Post-Operative Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32


List of Figures
Post-Operative Pain Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Post-Operative Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Post-Operative Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Post-Operative Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Post-Operative Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Post-Operative Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Post-Operative Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Post-Operative Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Post-Operative Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15 Post-Operative Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17 Post-Operative Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18 Proportion of Post-Operative Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 19 Post-Operative Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21 Post-Operative Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22 Post-Operative Pain Therapeutics, Global, Clinical Trials by Phase (%), 2016* 23 Post-Operative Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 24 Post-Operative Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25 Post-Operative Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26 Post-Operative Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27 Post-Operative Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 28 Post-Operative Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29 Post-Operative Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30 Post-Operative Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32 GlobalData Methodology 1695

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...

U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposable

Read More...

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify